000 | 01924 a2200625 4500 | ||
---|---|---|---|
005 | 20250517135057.0 | ||
264 | 0 | _c20170912 | |
008 | 201709s 0 0 eng d | ||
022 | _a1098-6596 | ||
024 | 7 |
_a10.1128/AAC.02382-16 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSutherland, Colin J | |
245 | 0 | 0 |
_aNone _h[electronic resource] |
260 |
_bAntimicrobial agents and chemotherapy _c03 2017 |
||
500 | _aPublication Type: Case Reports; Journal Article | ||
650 | 0 | 4 | _aAfrica |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAntimalarials _xtherapeutic use |
650 | 0 | 4 | _aArtemether, Lumefantrine Drug Combination |
650 | 0 | 4 |
_aArtemisinins _xtherapeutic use |
650 | 0 | 4 | _aDrug Combinations |
650 | 0 | 4 |
_aDrug Resistance _xgenetics |
650 | 0 | 4 |
_aEthanolamines _xtherapeutic use |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aFluorenes _xtherapeutic use |
650 | 0 | 4 | _aGene Expression |
650 | 0 | 4 | _aGenetic Loci |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aMalaria, Falciparum _xdrug therapy |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aParasitemia _xdrug therapy |
650 | 0 | 4 |
_aPlasmodium falciparum _xdrug effects |
650 | 0 | 4 |
_aProtozoan Proteins _xgenetics |
650 | 0 | 4 | _aRecurrence |
650 | 0 | 4 | _aTravel |
650 | 0 | 4 | _aTreatment Failure |
650 | 0 | 4 | _aUnited Kingdom |
650 | 0 | 4 | _aYoung Adult |
700 | 1 | _aLansdell, Paul | |
700 | 1 | _aSanders, Mandy | |
700 | 1 | _aMuwanguzi, Julian | |
700 | 1 | _avan Schalkwyk, Donelly A | |
700 | 1 | _aKaur, Harparkash | |
700 | 1 | _aNolder, Debbie | |
700 | 1 | _aTucker, Julie | |
700 | 1 | _aBennett, Hayley M | |
700 | 1 | _aOtto, Thomas D | |
700 | 1 | _aBerriman, Matthew | |
700 | 1 | _aPatel, Trupti A | |
700 | 1 | _aLynn, Roderick | |
700 | 1 | _aGkrania-Klotsas, Effrossyni | |
700 | 1 | _aChiodini, Peter L | |
773 | 0 |
_tAntimicrobial agents and chemotherapy _gvol. 61 _gno. 3 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1128/AAC.02382-16 _zAvailable from publisher's website |
999 |
_c26831952 _d26831952 |